Report cover image

Global Pets External Medicine Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 192 Pages
SKU # APRC20557415

Description

Summary

According to APO Research, the global Pets External Medicine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Pets External Medicine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Pets External Medicine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Pets External Medicine market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Pets External Medicine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Pets External Medicine market include Zoetis, Merck, Bayer, Virbac, Vetoquinol, Elanco, Chanelle, Ceva Sante Animale and Boehringer Ingelheim, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pets External Medicine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Pets External Medicine, also provides the sales of main regions and countries. Of the upcoming market potential for Pets External Medicine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pets External Medicine sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Pets External Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Pets External Medicine sales, projected growth trends, production technology, application and end-user industry.

Pets External Medicine Segment by Company

Zoetis
Merck
Bayer
Virbac
Vetoquinol
Elanco
Chanelle
Ceva Sante Animale
Boehringer Ingelheim
Bimeda Animal Health
Pets External Medicine Segment by Type

Injection
Unguent
Pets External Medicine Segment by Application

Cats
Dogs
Other
Pets External Medicine Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global Pets External Medicine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Pets External Medicine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Pets External Medicine significant trends, drivers, influence factors in global and regions.
6. To analyze Pets External Medicine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pets External Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pets External Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pets External Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pets External Medicine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pets External Medicine industry.
Chapter 3: Detailed analysis of Pets External Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Pets External Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Pets External Medicine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

192 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Pets External Medicine Sales Value (2020-2031)
1.2.2 Global Pets External Medicine Sales Volume (2020-2031)
1.2.3 Global Pets External Medicine Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Pets External Medicine Market Dynamics
2.1 Pets External Medicine Industry Trends
2.2 Pets External Medicine Industry Drivers
2.3 Pets External Medicine Industry Opportunities and Challenges
2.4 Pets External Medicine Industry Restraints
3 Pets External Medicine Market by Company
3.1 Global Pets External Medicine Company Revenue Ranking in 2024
3.2 Global Pets External Medicine Revenue by Company (2020-2025)
3.3 Global Pets External Medicine Sales Volume by Company (2020-2025)
3.4 Global Pets External Medicine Average Price by Company (2020-2025)
3.5 Global Pets External Medicine Company Ranking (2023-2025)
3.6 Global Pets External Medicine Company Manufacturing Base and Headquarters
3.7 Global Pets External Medicine Company Product Type and Application
3.8 Global Pets External Medicine Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Pets External Medicine Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Pets External Medicine Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Pets External Medicine Market by Type
4.1 Pets External Medicine Type Introduction
4.1.1 Injection
4.1.2 Unguent
4.2 Global Pets External Medicine Sales Volume by Type
4.2.1 Global Pets External Medicine Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Pets External Medicine Sales Volume by Type (2020-2031)
4.2.3 Global Pets External Medicine Sales Volume Share by Type (2020-2031)
4.3 Global Pets External Medicine Sales Value by Type
4.3.1 Global Pets External Medicine Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Pets External Medicine Sales Value by Type (2020-2031)
4.3.3 Global Pets External Medicine Sales Value Share by Type (2020-2031)
5 Pets External Medicine Market by Application
5.1 Pets External Medicine Application Introduction
5.1.1 Cats
5.1.2 Dogs
5.1.3 Other
5.2 Global Pets External Medicine Sales Volume by Application
5.2.1 Global Pets External Medicine Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Pets External Medicine Sales Volume by Application (2020-2031)
5.2.3 Global Pets External Medicine Sales Volume Share by Application (2020-2031)
5.3 Global Pets External Medicine Sales Value by Application
5.3.1 Global Pets External Medicine Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Pets External Medicine Sales Value by Application (2020-2031)
5.3.3 Global Pets External Medicine Sales Value Share by Application (2020-2031)
6 Pets External Medicine Regional Sales and Value Analysis
6.1 Global Pets External Medicine Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Pets External Medicine Sales by Region (2020-2031)
6.2.1 Global Pets External Medicine Sales by Region: 2020-2025
6.2.2 Global Pets External Medicine Sales by Region (2026-2031)
6.3 Global Pets External Medicine Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Pets External Medicine Sales Value by Region (2020-2031)
6.4.1 Global Pets External Medicine Sales Value by Region: 2020-2025
6.4.2 Global Pets External Medicine Sales Value by Region (2026-2031)
6.5 Global Pets External Medicine Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Pets External Medicine Sales Value (2020-2031)
6.6.2 North America Pets External Medicine Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Pets External Medicine Sales Value (2020-2031)
6.7.2 Europe Pets External Medicine Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Pets External Medicine Sales Value (2020-2031)
6.8.2 Asia-Pacific Pets External Medicine Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Pets External Medicine Sales Value (2020-2031)
6.9.2 South America Pets External Medicine Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Pets External Medicine Sales Value (2020-2031)
6.10.2 Middle East & Africa Pets External Medicine Sales Value Share by Country, 2024 VS 2031
7 Pets External Medicine Country-level Sales and Value Analysis
7.1 Global Pets External Medicine Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Pets External Medicine Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Pets External Medicine Sales by Country (2020-2031)
7.3.1 Global Pets External Medicine Sales by Country (2020-2025)
7.3.2 Global Pets External Medicine Sales by Country (2026-2031)
7.4 Global Pets External Medicine Sales Value by Country (2020-2031)
7.4.1 Global Pets External Medicine Sales Value by Country (2020-2025)
7.4.2 Global Pets External Medicine Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Pets External Medicine Sales Value Growth Rate (2020-2031)
7.5.2 USA Pets External Medicine Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Pets External Medicine Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Pets External Medicine Sales Value Growth Rate (2020-2031)
7.6.2 Canada Pets External Medicine Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Pets External Medicine Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Pets External Medicine Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Pets External Medicine Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Pets External Medicine Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Pets External Medicine Sales Value Growth Rate (2020-2031)
7.8.2 Germany Pets External Medicine Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Pets External Medicine Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Pets External Medicine Sales Value Growth Rate (2020-2031)
7.9.2 France Pets External Medicine Sales Value Share by Type, 2024 VS 2031
7.9.3 France Pets External Medicine Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Pets External Medicine Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Pets External Medicine Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Pets External Medicine Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Pets External Medicine Sales Value Growth Rate (2020-2031)
7.11.2 Italy Pets External Medicine Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Pets External Medicine Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Pets External Medicine Sales Value Growth Rate (2020-2031)
7.12.2 Spain Pets External Medicine Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Pets External Medicine Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Pets External Medicine Sales Value Growth Rate (2020-2031)
7.13.2 Russia Pets External Medicine Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Pets External Medicine Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Pets External Medicine Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Pets External Medicine Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Pets External Medicine Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Pets External Medicine Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Pets External Medicine Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Pets External Medicine Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Pets External Medicine Sales Value Growth Rate (2020-2031)
7.16.2 China Pets External Medicine Sales Value Share by Type, 2024 VS 2031
7.16.3 China Pets External Medicine Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Pets External Medicine Sales Value Growth Rate (2020-2031)
7.17.2 Japan Pets External Medicine Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Pets External Medicine Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Pets External Medicine Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Pets External Medicine Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Pets External Medicine Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Pets External Medicine Sales Value Growth Rate (2020-2031)
7.19.2 India Pets External Medicine Sales Value Share by Type, 2024 VS 2031
7.19.3 India Pets External Medicine Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Pets External Medicine Sales Value Growth Rate (2020-2031)
7.20.2 Australia Pets External Medicine Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Pets External Medicine Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Pets External Medicine Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Pets External Medicine Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Pets External Medicine Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Pets External Medicine Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Pets External Medicine Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Pets External Medicine Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Pets External Medicine Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Pets External Medicine Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Pets External Medicine Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Pets External Medicine Sales Value Growth Rate (2020-2031)
7.24.2 Chile Pets External Medicine Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Pets External Medicine Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Pets External Medicine Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Pets External Medicine Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Pets External Medicine Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Pets External Medicine Sales Value Growth Rate (2020-2031)
7.26.2 Peru Pets External Medicine Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Pets External Medicine Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Pets External Medicine Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Pets External Medicine Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Pets External Medicine Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Pets External Medicine Sales Value Growth Rate (2020-2031)
7.28.2 Israel Pets External Medicine Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Pets External Medicine Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Pets External Medicine Sales Value Growth Rate (2020-2031)
7.29.2 UAE Pets External Medicine Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Pets External Medicine Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Pets External Medicine Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Pets External Medicine Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Pets External Medicine Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Pets External Medicine Sales Value Growth Rate (2020-2031)
7.31.2 Iran Pets External Medicine Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Pets External Medicine Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Pets External Medicine Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Pets External Medicine Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Pets External Medicine Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Zoetis
8.1.1 Zoetis Comapny Information
8.1.2 Zoetis Business Overview
8.1.3 Zoetis Pets External Medicine Sales, Value and Gross Margin (2020-2025)
8.1.4 Zoetis Pets External Medicine Product Portfolio
8.1.5 Zoetis Recent Developments
8.2 Merck
8.2.1 Merck Comapny Information
8.2.2 Merck Business Overview
8.2.3 Merck Pets External Medicine Sales, Value and Gross Margin (2020-2025)
8.2.4 Merck Pets External Medicine Product Portfolio
8.2.5 Merck Recent Developments
8.3 Bayer
8.3.1 Bayer Comapny Information
8.3.2 Bayer Business Overview
8.3.3 Bayer Pets External Medicine Sales, Value and Gross Margin (2020-2025)
8.3.4 Bayer Pets External Medicine Product Portfolio
8.3.5 Bayer Recent Developments
8.4 Virbac
8.4.1 Virbac Comapny Information
8.4.2 Virbac Business Overview
8.4.3 Virbac Pets External Medicine Sales, Value and Gross Margin (2020-2025)
8.4.4 Virbac Pets External Medicine Product Portfolio
8.4.5 Virbac Recent Developments
8.5 Vetoquinol
8.5.1 Vetoquinol Comapny Information
8.5.2 Vetoquinol Business Overview
8.5.3 Vetoquinol Pets External Medicine Sales, Value and Gross Margin (2020-2025)
8.5.4 Vetoquinol Pets External Medicine Product Portfolio
8.5.5 Vetoquinol Recent Developments
8.6 Elanco
8.6.1 Elanco Comapny Information
8.6.2 Elanco Business Overview
8.6.3 Elanco Pets External Medicine Sales, Value and Gross Margin (2020-2025)
8.6.4 Elanco Pets External Medicine Product Portfolio
8.6.5 Elanco Recent Developments
8.7 Chanelle
8.7.1 Chanelle Comapny Information
8.7.2 Chanelle Business Overview
8.7.3 Chanelle Pets External Medicine Sales, Value and Gross Margin (2020-2025)
8.7.4 Chanelle Pets External Medicine Product Portfolio
8.7.5 Chanelle Recent Developments
8.8 Ceva Sante Animale
8.8.1 Ceva Sante Animale Comapny Information
8.8.2 Ceva Sante Animale Business Overview
8.8.3 Ceva Sante Animale Pets External Medicine Sales, Value and Gross Margin (2020-2025)
8.8.4 Ceva Sante Animale Pets External Medicine Product Portfolio
8.8.5 Ceva Sante Animale Recent Developments
8.9 Boehringer Ingelheim
8.9.1 Boehringer Ingelheim Comapny Information
8.9.2 Boehringer Ingelheim Business Overview
8.9.3 Boehringer Ingelheim Pets External Medicine Sales, Value and Gross Margin (2020-2025)
8.9.4 Boehringer Ingelheim Pets External Medicine Product Portfolio
8.9.5 Boehringer Ingelheim Recent Developments
8.10 Bimeda Animal Health
8.10.1 Bimeda Animal Health Comapny Information
8.10.2 Bimeda Animal Health Business Overview
8.10.3 Bimeda Animal Health Pets External Medicine Sales, Value and Gross Margin (2020-2025)
8.10.4 Bimeda Animal Health Pets External Medicine Product Portfolio
8.10.5 Bimeda Animal Health Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Pets External Medicine Value Chain Analysis
9.1.1 Pets External Medicine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Pets External Medicine Sales Mode & Process
9.2 Pets External Medicine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Pets External Medicine Distributors
9.2.3 Pets External Medicine Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.